• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ex-Medtronic CEO George: Trump’s anti-trade talk risks ‘crony capitalism’

Ex-Medtronic CEO George: Trump’s anti-trade talk risks ‘crony capitalism’

February 14, 2017 By Brad Perriello

NAFTAIf the administration acts on Donald Trump’s protectionist campaign rhetoric, it could cripple the U.S. economy and lead to “crony capitalism,” former Medtronic (NYSE:MDT) CEO Bill George said this week.

George, who led Medtronic from 1991 to 2001, said Trump’s vow to reward businesses for bringing jobs back to the U.S. “would lead to crony capitalism” as companies look to catch the White House’s eye.

In Minnesota, home to the largest medical device cluster in the country and more than a dozen Fortune 500 companies, exports were $20 billion in 2015. Mexico is the North Star State’s 2nd-largest trading partner, according to SCTimes.

“Global business has operated very much in Minnesota’s benefit,” George told the website. “If we go to America first, this could really harm Minnesota’s companies, harm our relationships, our ability to do business in China or Vietnam or Korea because that’s where the opportunities are, and that’s where a lot of companies have been putting their efforts in.”

“Globalization has gone a long ways in the last 20 years,” added Dave MacLennan, CEO at food & ag producer Cargill. “You can’t put that genie back in the bottle.

“Geopolitics are shifting and we are standing at the crossroads of some really important issues for business and for society,” MacLennan said in a speech at the University of St. Thomas this month, according to the site.

He and George are not alone it voicing their trepidation at the potential for any anti-free-trade action to wreak economic havoc. Intuitive Surgical (NSDQ:ISRG) this month warned of the risks posed to its business by the geopolitical shifts of the past year, including the U.S.’s threatened abrogation of the North American Free Trade Agreement.

Filed Under: Wall Street Beat Tagged With: Capitol Hill, North American Free Trade Agreement (NAFTA)

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy